Fulford Clinical Solutions Limited 05156526 false 2022-07-01 2023-06-30 2023-06-30 The principal activity of the company is that of a non trading company Digita Accounts Production Advanced 6.30.9574.0 true 05156526 2022-07-01 2023-06-30 05156526 2023-06-30 05156526 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 05156526 bus:Micro-entities 2022-07-01 2023-06-30 05156526 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 05156526 bus:FullAccounts 2022-07-01 2023-06-30 05156526 bus:SmallCompaniesRegimeForAccounts 2022-07-01 2023-06-30 05156526 bus:RegisteredOffice 2022-07-01 2023-06-30 05156526 bus:CompanySecretaryDirector1 2022-07-01 2023-06-30 05156526 bus:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 05156526 countries:England 2022-07-01 2023-06-30 05156526 2021-07-01 2022-06-30 05156526 2022-06-30 05156526 core:CurrentFinancialInstruments core:WithinOneYear 2022-06-30 iso4217:GBP xbrli:pure

Registration number: 05156526

Fulford Clinical Solutions Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 June 2023

 

Fulford Clinical Solutions Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

2

 

Fulford Clinical Solutions Limited

(Registration number: 05156526)
Balance Sheet as at 30 June 2023

2023
£

2022
£

Current assets

2,945

4,709

Creditors: Amounts falling due within one year

(39)

(26)

Total assets less current liabilities

2,906

4,683

Accruals and deferred income

(180)

(180)

 

2,726

4,503

Capital and reserves

2,726

4,503

 

Fulford Clinical Solutions Limited

(Registration number: 05156526)
Balance Sheet as at 30 June 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
80 Blewbury Drive
Tilehurst
Reading
Berkshire
RG31 5HL

These financial statements were authorised for issue by the Board on 5 March 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2022 - 0).

For the financial year ending 30 June 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved and authorised by the Board on 5 March 2024 and signed on its behalf by:
 

.........................................
S Fulford
Company secretary and director